89bio, Inc. (ETNB) Misses Q2 EPS by 6c
89bio, Inc. (NASDAQ: ETNB) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.
89bio, Inc. (NASDAQ: ETNB) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.